The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Does Treatment of Vulvar Lichen Sclerosus Influence Its Prognosis?
Abstract
OBJECTIVE: To record the clinical features, symptomatic response to topical steroids, and resolution of clinical signs in a large cohort of female patients with vulvar lichen sclerosus. DESIGN: Descriptive cohort study with a mean follow-up of 66 months. SETTING: The vulvar clinics of a teaching hospital and of a district general hospital in Oxfordshire, England. PATIENTS: Three hundred twenty-seven patients (74 girls and 253 women) with a definite clinical diagnosis of vulvar lichen sclerosus. Interventions The patients received topical steroids as part of their normal care. MAIN OUTCOME MEASURES: Symptomatic response to treatment (good, partial, or poor); response of the vulvar signs (total, partial, minor, or poor); and the presence or absence of moderate or severe scarring. RESULTS: The mean age at onset was 5.4 years in girls and 55.1 years in women and first-choice therapy was an ultrapotent topical steroid for 50% of the girls and 89% of the women. Response to treatment was recorded in 255 patients. In 244 patients (96%) symptoms improved with treatment, as 168 (66%) became symptom free and 76 (30%) showed partial response; 11 (4%) had poor response. Among the 253 patients in whom a response of the vulvar signs to topical steroid was recorded, 58 (23%) showed total response, with return to normal skin texture and color; and 173 (68%) showed partial, 18 (7%) showed minor, and 4 (2%) showed poor response. Moderate or severe scarring occurred less often in girls (P<.001). Squamous cell carcinoma developed in 6 women (2.4%). CONCLUSION: Topical ultrapotent steroid is an effective treatment for vulvar lichen sclerosus, giving relief of symptoms in most and completely reversing the skin changes in approximately one fifth of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lichen sclerosus et atrophicus and autoimmunity—a study of 350 women
THOMAS, R. H. M., RIDLEY, C. M., MCGIBBON, D. H., & BLACK, M. M. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb01748.x · Cited by 353
Autoantibodies to extracellular matrix protein 1 in lichen sclerosus
Oyama, N., Chan, I., Neill, S. M., Hamada, T., South, A. P., Wessagowit, V., Wojnarowska, F., D'Cruz, D., Hughes, G. J., Black, M. M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13863-9 · Cited by 322
Self-citationLichen sclerosus et atrophicus
(2004) · Dermatology Therapy · doi:10.1007/3-540-29668-9_1604 · Cited by 306
Childhood vulvar lichen sclerosus: An increasingly common problem
Powell, J., & Wojnarowska, F. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.113474 · Cited by 274
Self-citationLichen Sclerosus et Atrophicus
Abdullah-Al-Amin, M., Begum, S. N., & Pramanik, M. (1970) · TAJ: Journal of Teachers Association · doi:10.3329/taj.v17i1.3490 · Cited by 261
The association between lichen sclerosus and antigens of the HLA system
MARREN, P., JELL, J., CHARNOCK, F. M., BUNCE, M., WELSH, K., & WOJNAROWSKA, F. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb05013.x · Cited by 194
Self-citationLichen sclerosus premenarche: autoimmunity and immunogenetics
Powell, J., Wojnarowska, F., Winsey, S., Marren, P., & Welsh, K. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03360.x · Cited by 189
Self-citationDALZIEL, K. L., MILLARD, P. R., & WOJNAROWSKA, F. (1991) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1991.tb00626.x · Cited by 179
Self-citationSquamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study
Carli, P., Cattaneo, A., Magnis, A. D., Biggeri, A., Taddei, G., & Giannotti, B. (1995) · European Journal of Cancer Prevention · doi:10.1097/00008469-199512000-00008 · Cited by 166
Successful Treatment of Anogenital Lichen Sclerosus With Topical Tacrolimus
Böhm, M., Frieling, U. M., Luger, T. A., & Bonsmann, G. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.922 · Cited by 120
The association of lichen sclerosus et atrophicus and autoimmune-related disease in males
THOMAS, R. H. M., Ridley, C. M., & Black, M. M. (1983) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1983.tb00546.x · Cited by 104
Childhood vulvar lichen sclerosus. The course after puberty.
Powell, J., & Wojnarowska, F. (2002) · PubMed · Cited by 97
Self-citationTreatment of Childhood Vulvar Lichen Sclerosus with Potent Topical Corticosteroid
Fischer, G. O., & Rogers, M. (1997) · Pediatric Dermatology · doi:10.1111/j.1525-1470.1997.tb00247.x · Cited by 97
Tacrolimus ointment for the treatment of vulvar lichen sclerosus
Assmann, T., Becker-Wegerich, P. M., Grewe, M., Megahed, M., & Ruzicka, T. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.8 · Cited by 81
Ultrapotent Topical Corticosteroid Treatment of Childhood Genital Lichen Sclerosus
Garzón, M. C., & Paller, A. S. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.5.525 · Cited by 78
Lichen Sclerosus et Atrophicus in Children: A Report of 24 Cases
Clark, J. A. (1967) · Archives of Dermatology · doi:10.1001/archderm.95.5.476 · Cited by 64
Clobetasol Propionate in the Treatment of Premenarchal Vulvar Lichen Sclerosus
Smith, Y. R., & Quint, E. H. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01496-x · Cited by 62
Management of anogenital lichen sclerosus
Neill, S. M., & Ridley, C. M. (2001) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2001.00907.x · Cited by 53
Successful Treatment of Vulvar Lichen Sclerosus With Topical Tacrolimus
Kunstfeld, R. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.850 · Cited by 52
Lubach, D., Rath, J., & Kietzmann, M. (2009) · Dermatology · doi:10.1159/000246635 · Cited by 39
WALKDEN, Y. C. F. W. V. (1997) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443619768588 · Cited by 39
Cited by
Diagnosis and Treatment of Lichen Sclerosus: An Update
Fistarol, S. K., & Itin, P. H. (2013) · American Journal of Clinical Dermatology · doi:10.1007/s40257-012-0006-4 · Cited by 415
Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women
Lee, A., Bradford, J., & Fischer, G. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.0643 · Cited by 400
British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010
Neill, S. M., Lewis, F. M., Tatnall, F. M., & Cox, N. H. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09997.x · Cited by 369
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus
Kirtschig, G., Becker, K., Günthert, A., Jasaitiene, D., Cooper, S., Chi, C. ‐., Kreuter, A., Rall, K. K., Aberer, W., Riechardt, S., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13136 · Cited by 350
Self-citationLichen sclerosus: The 2023 update
De Luca, D. A., Papara, C., Vorobyev, A., Staiger, H., Bieber, K., Thaçi, D., & Ludwig, R. J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1106318 · Cited by 208
Metadata
- Authors
- Cooper, S. M., Gao, X.-H., Powell, J. J., & Wojnarowska, F.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-06-01
- Volume
- 140
- Issue
- 6
- Pages
- 702-6
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W1987172723
- Cited by
- 281
- References
- 21
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.